Significant reductions were seen in dementia risk for rivaroxaban, apixaban, and dabigatran versus warfarin in network meta-analysis
Your search for Warfarin returned 7 results
During extended treatment, bleeding risk was similar for apixaban and rivaroxaban.
Findings seen among adults prescribed warfarin, DOACs beyond 6 months after acute venous thromboembolism.
Balfaxar is a non-activated 4 factor prothrombin complex concentrate containing vitamin K-dependent factors.
No reduction seen in risk of antithrombotic events but increased risk of major and minor bleeding.
Tecarfarin is a novel oral vitamin K antagonist with a similar mechanism of action to warfarin, though it is metabolized differently.
Quality improvement effort tied to decrease in major bleeding without increase in thrombotic events